BiotechTube
Home/20/20 BioLabs/Michael Leibowitz, Ph.D.
ML

Michael Leibowitz, Ph.D.

Chief Scientific Officer

20/20 BioLabs

Therapeutic Areas

OncologyChronic Disease Prevention

20/20 BioLabs Pipeline

DrugIndicationPhase
OneTest for CancerMulti-Cancer Early Detection (MCED)Commercial
OneTest for LongevityChronic Inflammation & Disease RiskDevelopment

Leadership Team at 20/20 BioLabs

JC
Jonathan Cohen
President & CEO
JZ
Jiming Zhou, Ph.D.
Chief Operating Officer
RB
Ron Baker
Chief Business Officer
DL
David Lees
Director of Sales
View full 20/20 BioLabs profile